These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9864086)

  • 21. The dose-dependent effect of chronic administration of haloperidol, risperidone, and quetiapine on sexual behavior in the male rat.
    Zhang XR; Zhang ZJ; Jenkins TA; Cheng WR; Reynolds GP
    J Sex Med; 2011 Dec; 8(12):3345-53. PubMed ID: 20233290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome.
    Vurucu S; Congologlu A; Altun D; Unay B; Akin R
    J Natl Med Assoc; 2009 Mar; 101(3):273-5. PubMed ID: 19331262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hallucinogen persisting perception disorder after psilocybin consumption: a case study.
    Espiard ML; Lecardeur L; Abadie P; Halbecq I; Dollfus S
    Eur Psychiatry; 2005 Aug; 20(5-6):458-60. PubMed ID: 15963699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
    Homan EJ; Copinga S; Unelius L; Jackson DM; Wikström HV; Grol CJ
    Bioorg Med Chem; 1999 Jul; 7(7):1263-71. PubMed ID: 10465402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotics-induced hypersensitivity of visual perception.
    Uchida H; Suzuki T; Watanabe K; Kashima H
    Eur Psychiatry; 2006 Jul; 21(5):343-4. PubMed ID: 16860706
    [No Abstract]   [Full Text] [Related]  

  • 26. Risperidone-associated, benign transient visual disturbances in schizophrenic patients with a past history of LSD abuse.
    Lerner AG; Shufman E; Kodesh A; Rudinski D; Kretzmer G; Sigal M
    Isr J Psychiatry Relat Sci; 2002; 39(1):57-60. PubMed ID: 12013711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Injectable sustained-release risperidone: recurrence of delirium and treatment failure.
    Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131515
    [No Abstract]   [Full Text] [Related]  

  • 28. Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment.
    Doyle MA; Ling S; Lui LMW; Fragnelli P; Teopiz KM; Ho R; Di Vincenzo JD; Rosenblat JD; Gillissie ES; Nogo D; Ceban F; Jawad MY; McIntyre RS
    Expert Opin Drug Saf; 2022 Jun; 21(6):733-743. PubMed ID: 35426769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
    Leysen JE; Janssen PM; Megens AA; Schotte A
    J Clin Psychiatry; 1994 May; 55 Suppl():5-12. PubMed ID: 7520908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antipsychotic drug risperidone interacts with auto- and hetero-receptors regulating serotonin output in the rat frontal cortex.
    Hertel P; Nomikos GG; Svensson TH
    Neuropharmacology; 1999 Aug; 38(8):1175-84. PubMed ID: 10462130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 'Seroquel' (quetiapine) on platelet serotonin-2 binding in schizophrenia.
    Faustman WO; Ringo DL; Lauriello J; Lim KO; Pfefferbaum A
    J Clin Psychopharmacol; 1996 Dec; 16(6):464-6. PubMed ID: 8959478
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone.
    Kuwilsky A; Krumm B; Englisch S; Dressing H; Zink M
    Pharmacopsychiatry; 2010 Aug; 43(6):216-20. PubMed ID: 20589598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extrapyramidal syndrome].
    Nakagawa S; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):179-82. PubMed ID: 12876960
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.
    Marcus MM; Wiker C; Frånberg O; Konradsson-Geuken A; Langlois X; Jardemark K; Svensson TH
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):891-903. PubMed ID: 19835668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An open trial of risperidone in autistic children].
    Nishimura M; Hashimoto T; Miyazaki M; Mori K; Kuroda Y
    No To Hattatsu; 2003 Nov; 35(6):473-7. PubMed ID: 14631742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
    Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat.
    McDaid J; Docherty JR
    Br J Pharmacol; 2001 Jun; 133(3):429-37. PubMed ID: 11375260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
    Varty GB; Bakshi VP; Geyer MA
    Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of serotonin receptors in the action of atypical antipsychotic drugs.
    Meltzer HY; Massey BW
    Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of central serotonergic neurotransmission by risperidone: underlying mechanism(s) and significance of action.
    Hertel P; Lindblom N; Nomikos GG; Svensson TH
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):815-34. PubMed ID: 9723122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.